AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Convatec Group PLC

AGM Information May 11, 2018

4959_agm-r_2018-05-11_6218c11d-5b27-48b4-9f37-6c7ecc1365d0.html

AGM Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8674N

ConvaTec Group PLC

11 May 2018

Result of Meeting

CONVATEC GROUP PLC - AGM

11 MAY 2018 - CORRECTED POLL RESULT

ConvaTec Group Plc ("ConvaTec"), a leading global medical products and technologies company, held its annual general meeting today.  The results of the poll held in relation to the resolutions proposed at the meeting are set out below. The number of votes withheld has been corrected and a column of number of votes cast included.

For (see note 2) Against (see note 2) Number of votes withheld (see note 3) Number of votes cast Total Capital Instructed
Resolution No of shares % No of Shares %
1 Receive Annual Report and Accounts 1,490,995,091 100.00 2,052 0.00 429,366 1,490,997,143 76.39%
2 Approve the Directors' Remuneration Report 1,457,090,861 98.33 24,766,857 1.67 9,568,789 1,481,857,718 75.92%
3 Declare Final Dividend 1,490,997,143 100.00 0 0.00 429,366 1,490,997,143 76.39%
4 Re-elect Sir Christopher Gent as a Director 1,483,108,674 99.47 7,885,399 0.53 432,436 1,490,994,073 76.39%
5 Re-elect Paul Moraviec as a Director 1,488,939,928 99.86 2,054,145 0.14 432,436 1,490,994,073 76.39%
6 Elect Frank Schulkes as a Director 1,481,688,827 99.38 9,305,246 0.62 432,436 1,490,994,073 76.39%
7 Re-elect Steve Holliday as a Director 1,482,717,535 99.44 8,277,540 0.56 431,434 1,490,995,075 76.39%
8 Re-elect Jesper Ovesen as a Director 1,476,891,196 99.05 14,102,877 0.95 432,436 1,490,994,073 76.39%
9 Re-elect Rick Anderson as a Director 1,488,985,560 99.87 2,009,487 0.13 431,462 1,490,995,047 76.39%
10 Re-elect Kasim Kutay as a Director 1,488,564,111 99.84 2,429,436 0.16 432,962 1,490,993,547 76.39%
11 Elect Ros Rivaz as a Director 1,486,522,754 99.70 4,471,319 0.30 432,436 1,490,994,073 76.39%
12 Elect Regina Benjamin as a Director 1,488,488,383 99.83 2,506,166 0.17 431,960 1,490,994,549 76.39%
13 Elect Margaret Ewing as a Director 1,488,980,460 99.86 2,014,587 0.14 431,462 1,490,995,047 76.39%
14 Re-appoint Deloitte LLP as auditors 1,490,989,671 100.00 6,418 0.00 430,420 1,490,996,089 76.39%
15 Authorise the Directors to agree the auditors' remuneration 1,490,994,110 100.00 3,033 0.00 429,366 1,490,997,143 76.39%
16 Authorise allotment of shares 1,479,661,716 99.25 11,131,674 0.75 633,119 1,490,793,390 76.38%
17 Disapply pre-emption rights* 1,490,781,972 99.99 213,817 0.01 430,720 1,490,995,789 76.39%
18 Disapply pre-emption rights in connection with an acquisition or specified capital investment* 1,428,938,102 95.84 62,052,586 4.16 435,820 1,490,990,688 76.39%
19 Authorise purchase of own shares* 1,485,284,913 99.75 3,698,352 0.25 2,443,243 1,488,983,265 76.29%
20 Authorise political donations and political expenditure 1,485,209,550 99.91 1,303,630 0.09 4,913,329 1,486,513,180 76.16%
21 Call general meetings on 14 days' notice* 1,442,987,025 97.07 43,526,671 2.93 4,912,813 1,486,513,696 76.16%

*Special Resolution

NOTES:

1.   All resolutions were passed.

2.   Votes "For" and "Against" are expressed as a percentage of votes received.

3.   A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

4.   Total number of shares in issue at 6.30pm on 8 May 2018 was 1,951,850,599 shares.  Up to 76.39% of voting capital was instructed.

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care.  www.convatecgroup.com

This information is provided by RNS

The company news service from the London Stock Exchange

Enquiries

Analysts and Investors

John Crosse, VP Investor Relations                                             +44 (0)7500 141 435

Kirsty Law, Director Investor Relations                                         +44 (0)7470 909 582

[email protected]

Media

Bobby Leach, VP Group Corporate Affairs                                    +44 (0)7770 842 226

Finsbury                                                                                    +44 (0)207 251 3801

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

# # #

END

This information is provided by RNS

The company news service from the London Stock Exchange

END

AGMSFDFLFFASEEI

Talk to a Data Expert

Have a question? We'll get back to you promptly.